Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Is a Promising Signature to Predict Prognosis and Therapies for Hepatocellular Carcinoma (HCC).

Yuyan Chen,Senzhe Xia,Lu Zhang,Xueqian Qin,Zhengyi Zhu,Tao Ma,Shushu Lu,Jing Chen,Xiaolei Shi,Haozhen Ren

Journal of clinical medicine（2023）

引用 0|浏览9

暂无评分

摘要

MAM score is a promising index for determining the need for chemotherapy, which reflects the energy metabolic pathways. A combination of the MAM score and TME score could be a better indicator to predict prognosis and response to immune therapy.

查看译文

关键词

chemotherapy,hepatocellular carcinoma,immune therapy,mitochondria-associated endoplasmic reticulum membrane,tumor microenvironment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要